Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
Status:
Completed
Trial end date:
2020-12-08
Target enrollment:
Participant gender:
Summary
Clinical phase I, controlled, non comparative, open, single center study evaluating the
safety and tolerability of ophthalmic solution PRO-172 when applied on the ocular surface of
healthy volunteers.